Biotech Voices

Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Our contributors are not paid for their opinions.

Have any questions or feedback, or think you have a voice that should be heard? Reach out to Amber Tong.

Log in to your account

email

password

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

Biotech Voices

Biotech Voices channel feed

Kristen Hege recounts an important chapter in CAR-T history — and how that compares to an adventurous coastal thru-hike

Kristen Hege reflects on the birth of CAR-T research as she reaches the 'end of the beginning' of her PCT thru-hike

#trekfortomorrow #3: How to survive the rigors of the Pacific Crest Trail and a career in cancer research

#trekfortomorrow: Early lessons from the trail

A career in cancer research turns out to be the perfect prep for a grueling personal adventure

Compassionate Use/Expanded Access programs: Three steps to improve their implementation for the benefit of all

Guest column: What happened with Esperion — and what defines success or failure?

6 key clinical trial trends that we should embrace and build on

8 ways China could help transform the global biopharma industry

Aducanumab has its approval — now, let citizen-scientists come together to see if it works

RNA: From the messenger to the medicine

The right to vote is fundamental — a letter from biotechnology industry leaders

The continuing CRISPR patent saga

Innovation in the clinic is picking up steam. How adaptive designs could pave the road to personalized medicine

How we are staying connected when we’re apart

The path to NASH: understanding the role of severe obesity in a complex, multi-system disease

Industry leaders need to speak out now more than ever

Why mucosal immunity may be required to end the pandemic

How will the Biden administration affect funding for life science research?

Revisiting the 'cytokine storm' in ARDS; the painful wait for anti-inflammatory drugs/targets that solve Covid-19 deaths

We’re poised for a new era of medical advances. A key step: understanding the molecular machines that govern health and disease

Next-gen therapies are evolving fast. The drug development model needs to keep up

Bioscience industry stakeholder collaboration key to addressing inequality

Biotech Voices: Coronavirus will change biotech research with remote collaborations